|
July 8, 2002
STATIN-INDUCED CARDIOMYOPATHY
INTRODUCTION TO THE CITIZEN’S PETITION ON STATINS
By
Peter H. Langsjoen, MD
The
medical profession has, after more than 30 years of excellent
propaganda, successfully created the wholly iatrogenic -
"pseudo-disease" dubbed "hypercholesterolemia" and the associated
malady "cholesterol neurosis". After decades of dismal failure to
cure this "disease" of numbers with low fat diets and a host of
cholesterol lowering drugs, the medical profession stumbled upon the
magic bullet, the cure for this dreaded artificial disease - statins
(HMG-CoA reductase inhibitors). First released on the US market in
1987, statins have rapidly grown into one of the most widely
prescribed class of drugs in history. Statins do three
things:
1. They
block the body's ability to make cholesterol, thus lowering the
blood level of cholesterol, thereby curing cholesterol neurosis.
Doctors and patients equally neurotic have immediate gratification.
The "evil" high cholesterol has been dramatically lowered and the
future is bright and promising. So far...so good.
2.
Unrelated to their cholesterol lowering, statins have been found to
have anti-inflammatory, plaque-stabilizing properties which have a
slight benefit in coronary heart disease.
3.
Statins kill people - lots of people - and they wound many, many
more. All patients taking statins become depleted in Coenzyme Q10
(CoQ10), eventually - those patients who start with a relatively low
CoQ10 levels (the elderly and patients with heart failure) begin to
manifest signs/symptoms of CoQ10 deficiency relatively rapidly - in
6 to 12 months. Younger, healthier people who's only "illness" is
the non-illness "hypercholesterolemia" can tolerate statins for
several years before getting into trouble with fatigue, muscle
weakness and soreness (usually with normal muscle enzyme CPK tests)
and most ominously - heart failure.
In my
practice of 17 years in Tyler, Texas, I have seen a frightening
increase in heart failure secondary to statin usage, "statin
cardiomyopathy". Over the past five years, statins have become more
potent, are being prescribed in higher doses, and are being used
with reckless abandon in the elderly and in patients with "normal"
cholesterol levels. We are in the midst of a CHF epidemic in the US
with a dramatic increase over the past decade. Are we causing this
epidemic through our zealous use of statins? In large part I think
the answer is yes. We are now in a position to witness the unfolding
of the greatest medical tragedy of all time - never before in
history has the medical establishment knowingly (Merck &
Co., Inc. has two 1990 patents combining CoQ10 with statins to
prevent CoQ10 depletion and attendant side effects) created a life
threatening nutrient deficiency in millions of otherwise healthy
people, only to then sit back with arrogance and horrific
irresponsibility and watch to see what happens - as I see two to
three new statin cardiomyopathies per week in my practice, I cannot
help but view my once great profession with a mixture of sorrow and
contempt.
Statin-induced CoQ10 depletion is the topic of a recent
petition to the FDA requesting that this drug/nutrient interaction
be identified in a black box warning as part of statin package
insert information. A comprehensive review of animal and human
trials addressing this issue has been submitted to the FDA as a
supporting document. We, of course, do not expect any response from
the FDA, but 10 years from now when the full extent of statin
toxicity becomes painfully evident, at least we can, in good
conscience, know that we tried and who knows, sometimes small sparks
may spread in dry grass.
See
Also:
Cholesterol Drugs And The Depletion Of Coenzyme Q10: A
Review Of Human And Animal Data. By Peter H. Langsjoen, MD
Citizen Petition: Needed - A Change In The Labeling Of
All Statin Drugs
|